Concepedia

Eslam M.H. Ali

EM

Statistics

Publications

13

Citations

339

H-Index

12

Active since

2016

Affiliations

Korea University of Science and Technology(Current)

National Research Centre

Korea Institute of Science and Technology

Modern University for Information and Technology

Ahram Canadian University

Eslam M.H. Ali is an author at Korea University of Science and Technology specializing in pharmacy, medicinal chemistry, and drug design.

ORCID

Publications per year

2016–2025

13

Publications

13

Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents

Nasser S. M. Ismail, Eslam M.H. Ali, Diaa A. Ibrahim et al. · Future Journal of Pharmaceutical Sciences · 2016 · 54 citations · Full text

, , +15

Discovery of New Imidazo[2,1-<i>b</i>]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising <i>In Vitro</i> and <i>In Vivo</i> Anti-melanoma Activity

Mohammed S. Abdel‐Maksoud, Mohammed I. El–Gamal, Bong S. Lee et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

, , +13

Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor

Eslam M.H. Ali, Mohammed S. Abdel‐Maksoud, Rasha M. Hassan et al. · Bioorganic & Medicinal Chemistry · 2020 · 37 citations · Full text

, , +12

Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Einhibitors

Eslam M.H. Ali, Mohammed S. Abdel‐Maksoud, Usama M. Ammar et al. · Bioorganic Chemistry · 2020 · 35 citations

, , +10

Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors

Mohammed S. Abdel‐Maksoud, Usama M. Ammar, Mohammed I. El–Gamal et al. · Bioorganic Chemistry · 2019 · 29 citations

, , +11

1–5 of 13